Clinical Trial

Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients with Long COVID

Study acronym: RESPICARE
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 18, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate whether a 12-week tele-rehabilitation programme with monitoring via a mobile app produces medium-term improvements in self-management, fatigue and quality of life in patients affected by persistent COVID. The main questions it aims to answer are: * Will a multimodal program (exercise with education) improve the self-management ability of patients with post-exertional malaise? * Does fatigue and quality of life will be improved in these patients? Researchers will compare an experimental breath program to a control standard care group to see if multimodal program works to treat post-exertion malaise. Participants will: * Follow-up 12 weeks online sessions: 1 weekly synchronous online session + 1 scheduled asynchronous session + educational resources * Daily use of the app: daily log, education and questions
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-11.
Trial Details
NCT Number NCT06822179
Lead Sponsor CEU San Pablo University
Conditions Long COVID Syndrome
Enrollment 60 participants
Start Date 2025-03
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-02-18